Postmarketing Reporting of Adverse Drug Experiences

This course explores the process for reporting postmarketing adverse drug experiences to FDA. Topics in this course include: Reports and Requirements. After completing this course, learners will be able to identify the process for reporting postmarketing adverse drug experiences to FDA.

After this course learners will be able to identify the process for reporting postmarketing adverse drug experiences to fda.